Showing results (31-40 of 82) with videos related to
Sort By:
Pageof 9
Clinical Nephrology|January 25, 2006
Urinary liver-type fatty acid-binding protein levels for differential diagnosis of idiopathic focal glomerulosclerosis and minor glomerular abnormalities and effect of low-density lipoprotein apheresisT Nakamura, T Sugaya, Y Kawagoe, et al.Optics Letters|July 1, 1997
Self-starting mode-locked femtosecond forsterite laser with a semiconductor saturable-absorber mirrorZ Zhang, K Torizuka, T Itatani, et al.Anesthesia and Analgesia|June 1, 1995
Inadequate antagonism of vecuronium-induced neuromuscular block by neostigmine during sevoflurane or isoflurane anesthesiaT Morita, H Tsukagoshi, T Sugaya, et al.Journal of Periodontal Research|July 11, 2006
Dentin resorption and cementum-like tissue formation by bone morphogenetic protein applicationH Miyaji, T Sugaya, K Kato, et al.Journal of Anesthesia|July 11, 2013
Neuromuscular effects of sevoflurane in patients with myasthenia gravisT Morita, H Tsukagoshi, D Kurosaki, et al.Kidney International|March 28, 2008
Renal L-type fatty acid-binding protein mediates the bezafibrate reduction of cisplatin-induced acute kidney injuryK Negishi, E Noiri, R Maeda, et al.Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 20, 2007
The involvement of type 1a angiotensin II receptors in the regulation of airway inflammation in a murine model of allergic asthmaK Ohwada, K Watanabe, K Okuyama, et al.Virchows Archiv : an International Journal of Pathology|November 10, 1998
Angiotensin II maintains the structure and function of glomerular mesangium via type 1a receptor. What we have learned from null mutant mice minus the angiotensin II type 1a receptor geneS Inokuchi, K Kimura, T Sugaya, et al.Kidney International|May 15, 2007
A role of liver fatty acid-binding protein in cisplatin-induced acute renal failureK Negishi, E Noiri, T Sugaya, et al.Biological & Pharmaceutical Bulletin|February 3, 1998
Bronchial anti-spasmogenic effects and selectivity of T-440, phosphodiesterase type 4 inhibitor, in the dogS Yamagata, K Wada, T Sugaya, et al.Pageof 9